|
US5989463A
(en)
*
|
1997-09-24 |
1999-11-23 |
Alkermes Controlled Therapeutics, Inc. |
Methods for fabricating polymer-based controlled release devices
|
|
US6183746B1
(en)
|
1997-10-09 |
2001-02-06 |
Zycos Inc. |
Immunogenic peptides from the HPV E7 protein
|
|
US6013258A
(en)
*
|
1997-10-09 |
2000-01-11 |
Zycos Inc. |
Immunogenic peptides from the HPV E7 protein
|
|
KR20000022894A
(ko)
*
|
1998-09-05 |
2000-04-25 |
이승진 |
생분해성 고분자 미립자형 제제 및 그 제조방법
|
|
AU5532699A
(en)
*
|
1998-09-05 |
2000-03-27 |
Seung Jin Lee |
Biodegradable particulate polymeric preparation and process for producing thereof
|
|
DE19848849A1
(de)
*
|
1998-10-22 |
2000-04-27 |
Knoll Ag |
Verfahren zur Herstellung von festen, sphärischen Formen, enthaltend eine biologisch aktive Substanz
|
|
JP2002534371A
(ja)
*
|
1999-01-06 |
2002-10-15 |
コリア リサーチ インスティテュート オブ ケミカル テクノロジー |
水不溶性薬物を含む医薬的活性成分の製造方法及びそれを含む経口投与用医薬組成物
|
|
US6159491A
(en)
*
|
1999-02-12 |
2000-12-12 |
Biovector Technologies, Inc. |
Prolonged release bioadhesive vaginal gel dosage form
|
|
KR100372751B1
(ko)
*
|
1999-11-16 |
2003-02-17 |
한국과학기술원 |
생체조직공학용 다공성 생분해성 고분자 지지체의 제조방법
|
|
US6440463B1
(en)
*
|
1999-04-05 |
2002-08-27 |
Pharmaceutical Discovery Corporation |
Methods for fine powder formation
|
|
AU3957400A
(en)
*
|
1999-04-16 |
2000-11-02 |
Novo Nordisk A/S |
Dry, mouldable drug formulation
|
|
US7759113B2
(en)
*
|
1999-04-30 |
2010-07-20 |
The General Hospital Corporation |
Fabrication of tissue lamina using microfabricated two-dimensional molds
|
|
US6455311B1
(en)
*
|
1999-04-30 |
2002-09-24 |
The General Hospital Corporation |
Fabrication of vascularized tissue
|
|
US7371400B2
(en)
|
2001-01-02 |
2008-05-13 |
The General Hospital Corporation |
Multilayer device for tissue engineering
|
|
US6291013B1
(en)
|
1999-05-03 |
2001-09-18 |
Southern Biosystems, Inc. |
Emulsion-based processes for making microparticles
|
|
US6444223B1
(en)
|
1999-05-28 |
2002-09-03 |
Alkermes Controlled Therapeutics, Inc. |
Method of producing submicron particles of a labile agent and use thereof
|
|
AU779277B2
(en)
*
|
1999-06-04 |
2005-01-13 |
Alza Corporation |
Implantable gel compositions and method of manufacture
|
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
|
EP1074248A1
(en)
*
|
1999-07-08 |
2001-02-07 |
Arnold Hilgers |
Delivery system for biological material
|
|
US6822086B1
(en)
*
|
1999-08-09 |
2004-11-23 |
The General Hospital Corporation |
Drug-carrier complexes and methods of use thereof
|
|
US8106098B2
(en)
*
|
1999-08-09 |
2012-01-31 |
The General Hospital Corporation |
Protein conjugates with a water-soluble biocompatible, biodegradable polymer
|
|
AU6536400A
(en)
*
|
1999-08-11 |
2001-03-05 |
Alkermes Controlled Therapeutics, Inc. |
Method of delivering a chemotherapeutic agent to a solid tumor
|
|
US6284283B1
(en)
|
1999-10-21 |
2001-09-04 |
Alkermes Controlled Therapeutics, Inc. |
Method of producing sub-micron particles of biologically active agents and uses thereof
|
|
WO2001030320A1
(en)
*
|
1999-10-22 |
2001-05-03 |
Amgen Inc. |
Biodegradable microparticles with novel erythropoietin stimulating protein
|
|
US20010007083A1
(en)
*
|
1999-12-29 |
2001-07-05 |
Roorda Wouter E. |
Device and active component for inhibiting formation of thrombus-inflammatory cell matrix
|
|
US7029700B2
(en)
*
|
2000-01-14 |
2006-04-18 |
Brown University Research Foundation |
Micronized freeze-dried particles
|
|
US7833549B2
(en)
*
|
2000-01-19 |
2010-11-16 |
Mannkind Corporation |
Dry powder formulations of antihistamine for nasal administration
|
|
EP1261427B1
(en)
*
|
2000-03-02 |
2011-03-02 |
Microchips, Inc. |
Microfabricated devices and methods for storage and selective exposure of chemicals
|
|
US7074803B2
(en)
*
|
2001-03-02 |
2006-07-11 |
Durect Corporation |
Opioid formulations
|
|
EP1272231A1
(en)
|
2000-04-06 |
2003-01-08 |
University Technology Corporation |
Compositions and methods for promoting wound healing
|
|
US7776021B2
(en)
|
2000-04-28 |
2010-08-17 |
The Charles Stark Draper Laboratory |
Micromachined bilayer unit for filtration of small molecules
|
|
EP1313425B1
(en)
*
|
2000-07-14 |
2007-03-07 |
Novo Nordisk A/S |
Method of moulding a pharmaceutical composition in a packaging material
|
|
US6362308B1
(en)
|
2000-08-10 |
2002-03-26 |
Alkermes Controlled Therapeutics Inc. Ii |
Acid end group poly(d,l-lactide-co-glycolide) copolymers high glycolide content
|
|
JP2004505761A
(ja)
|
2000-08-15 |
2004-02-26 |
ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ |
微小粒子
|
|
US6565888B1
(en)
|
2000-08-23 |
2003-05-20 |
Alkermes Controlled Therapeutics, Inc. |
Methods and compositions for the targeted delivery of biologically active agents
|
|
DE60144524D1
(de)
*
|
2000-09-01 |
2011-06-09 |
Palmaya Pty Ltd |
Pharmazeutische zubereitung und methode diese zu verabreichen
|
|
US7666445B2
(en)
|
2000-10-20 |
2010-02-23 |
The Trustees Of The University Of Pennsylvania |
Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
|
|
EP2295578A3
(en)
|
2000-10-31 |
2011-07-06 |
Eisai Inc. |
Cyp1b1 nucleic acids and methods of use
|
|
US20020151876A1
(en)
*
|
2001-02-07 |
2002-10-17 |
Tai-Wah Chan |
Devices and methods for management of bone density
|
|
CZ20033160A3
(en)
*
|
2001-05-23 |
2004-03-17 |
Hexal Ag |
Implant manufacturing process by means of solvent free preparation of a homogenate
|
|
US6730772B2
(en)
|
2001-06-22 |
2004-05-04 |
Venkatram P. Shastri |
Degradable polymers from derivatized ring-opened epoxides
|
|
WO2003014224A1
(en)
*
|
2001-08-03 |
2003-02-20 |
Toray Industries, Inc. |
Resin composition and molded article, film, and fiber each comprising the same
|
|
US7687053B2
(en)
|
2001-08-20 |
2010-03-30 |
Boston Scientific Scimed, Inc. |
Embolic compositions with non-cyanoacrylate rheology modifying agents
|
|
US8454997B2
(en)
|
2001-12-18 |
2013-06-04 |
Novo Nordisk A/S |
Solid dose micro implant
|
|
US7190781B2
(en)
*
|
2002-01-04 |
2007-03-13 |
Telefonaktiebolaget Lm Ericsson (Publ) |
Message transfer part point code mapping method and node
|
|
AU2003209227A1
(en)
|
2002-01-14 |
2003-07-30 |
The General Hospital Corporation |
Biodegradable polyketal polymers and methods for their formation and use
|
|
WO2003070905A2
(en)
*
|
2002-02-15 |
2003-08-28 |
Zycos, Inc. |
Electroporation methods for introducing bioactive agents into cells
|
|
US8728510B1
(en)
|
2002-03-15 |
2014-05-20 |
Advanced Cardiovascular Systems, Inc. |
Biocompatible carrier containing a bioadhesive material
|
|
ES2300568T3
(es)
|
2002-03-20 |
2008-06-16 |
Mannkind Corporation |
Aparato de inhalacion.
|
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
|
EP1534269B1
(en)
|
2002-07-19 |
2013-10-30 |
The General Hospital Corporation |
Oxime conjugates and methods for their formation and use
|
|
GB2399084B
(en)
*
|
2002-07-30 |
2007-01-31 |
Univ Liverpool |
Porous beads and method of production thereof
|
|
GB0222522D0
(en)
|
2002-09-27 |
2002-11-06 |
Controlled Therapeutics Sct |
Water-swellable polymers
|
|
CN1694689A
(zh)
*
|
2002-09-30 |
2005-11-09 |
阿库斯菲尔公司 |
供吸入的缓释多孔微粒
|
|
US6800663B2
(en)
*
|
2002-10-18 |
2004-10-05 |
Alkermes Controlled Therapeutics Inc. Ii, |
Crosslinked hydrogel copolymers
|
|
EP1589814B1
(en)
|
2003-01-16 |
2009-08-12 |
The General Hospital Corporation |
Use of three-dimensional microfabricated tissue engineered systems for pharmacologic applications
|
|
US7658998B2
(en)
*
|
2003-01-22 |
2010-02-09 |
Alkermes Controlled Therapeutics, Inc. |
Method of preparing sustained release microparticles
|
|
DE10303584A1
(de)
*
|
2003-01-30 |
2004-08-12 |
Stauss, Robert, Dr. |
Verwendung von Erythropoietin (EPO) als ein Beschichtungsmaterial auf medizinischen Implantaten
|
|
US7736391B2
(en)
|
2003-02-06 |
2010-06-15 |
Tonaba Healthscience Ii, Llc |
Cosmetic and reconstructive prostheses with a microencapsulated biologically compatible rupture indicator for sustained release and methods of detecting compromise of a prosthesis
|
|
WO2004084819A2
(en)
*
|
2003-03-19 |
2004-10-07 |
University Of Kentucky Research Foundation |
Poly(acryloyl-hydroxyethyl starch)-plga composite microspheres
|
|
US7051485B2
(en)
*
|
2003-04-29 |
2006-05-30 |
Greg Burnette |
Ceiling panel system
|
|
US7960166B2
(en)
|
2003-05-21 |
2011-06-14 |
The General Hospital Corporation |
Microfabricated compositions and processes for engineering tissues containing multiple cell types
|
|
DE10361596A1
(de)
*
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
|
US7790150B2
(en)
*
|
2003-09-05 |
2010-09-07 |
The General Hospital Corporation |
Dual phase drug release system
|
|
WO2005032511A2
(en)
*
|
2003-09-30 |
2005-04-14 |
Spherics, Inc. |
Nanoparticulate therapeutic biologically active agents
|
|
CN1856296A
(zh)
*
|
2003-09-30 |
2006-11-01 |
阿库斯菲尔公司 |
可注射的、口服、或局部用缓释药物制剂
|
|
US7309500B2
(en)
*
|
2003-12-04 |
2007-12-18 |
The Board Of Trustees Of The University Of Illinois |
Microparticles
|
|
BRPI0418326A
(pt)
*
|
2003-12-30 |
2007-05-02 |
Bionethos Holding Gmbh |
método de regeneração de tecidos
|
|
US8221778B2
(en)
|
2005-01-12 |
2012-07-17 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
|
US8329203B2
(en)
*
|
2004-01-12 |
2012-12-11 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
|
EP2633853A1
(en)
*
|
2004-01-12 |
2013-09-04 |
The Trustees of The University of Pennsylvania |
Long-term delivery formulations and methods of use thereof
|
|
WO2005072702A2
(en)
*
|
2004-01-20 |
2005-08-11 |
Alkermes Controlled Therapeutics, Inc. |
Method for milling frozen microparticles
|
|
US20050188921A1
(en)
*
|
2004-02-27 |
2005-09-01 |
Anthony Malone |
Matrix assisted pulsed-laser evaporation technique for coating a medical device and associated system and medical device
|
|
CA2561014C
(en)
*
|
2004-04-08 |
2013-09-10 |
Wyeth |
Thioamide derivatives as progesterone receptor modulators
|
|
JP5039541B2
(ja)
*
|
2004-04-27 |
2012-10-03 |
ワイス・エルエルシー |
プロゲステロン受容体調節剤の精製
|
|
ES2527286T3
(es)
*
|
2004-04-30 |
2015-01-22 |
Abraxis Bioscience, Llc |
Microesferas de liberación sostenida y métodos de fabricación y uso de las mismas
|
|
US8062652B2
(en)
*
|
2004-06-17 |
2011-11-22 |
Endo Pharmaceuticals Solutions Inc. |
Compositions and methods for treating precocious puberty
|
|
DE102004032049A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
|
ES2432556T3
(es)
|
2004-08-04 |
2013-12-04 |
Evonik Corporation |
Métodos para fabricar dispositivos de suministro y sus dispositivos
|
|
GB0417401D0
(en)
|
2004-08-05 |
2004-09-08 |
Controlled Therapeutics Sct |
Stabilised prostaglandin composition
|
|
WO2006023849A2
(en)
|
2004-08-20 |
2006-03-02 |
Mannkind Corporation |
Catalysis of diketopiperazine synthesis
|
|
KR20150039211A
(ko)
|
2004-08-23 |
2015-04-09 |
맨카인드 코포레이션 |
약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
|
|
US8367099B2
(en)
|
2004-09-28 |
2013-02-05 |
Atrium Medical Corporation |
Perforated fatty acid films
|
|
US8001922B2
(en)
|
2004-09-28 |
2011-08-23 |
Atrium Medical Corporation |
Application of a coating on a medical device
|
|
US9000040B2
(en)
|
2004-09-28 |
2015-04-07 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
|
US9801982B2
(en)
|
2004-09-28 |
2017-10-31 |
Atrium Medical Corporation |
Implantable barrier device
|
|
US9012506B2
(en)
|
2004-09-28 |
2015-04-21 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
|
US8858978B2
(en)
|
2004-09-28 |
2014-10-14 |
Atrium Medical Corporation |
Heat cured gel and method of making
|
|
US8312836B2
(en)
|
2004-09-28 |
2012-11-20 |
Atrium Medical Corporation |
Method and apparatus for application of a fresh coating on a medical device
|
|
US8834901B2
(en)
*
|
2004-10-14 |
2014-09-16 |
Trustees Of Tufts College |
Electrochemically degradable polymers
|
|
US7748343B2
(en)
|
2004-11-22 |
2010-07-06 |
The Board Of Trustees Of The University Of Illinois |
Electrohydrodynamic spraying system
|
|
US20080213593A1
(en)
*
|
2005-01-21 |
2008-09-04 |
President And Fellows Of Harvard College |
Systems And Methods For Forming Fluidic Droplets Encapsulated In Particles Such As Colloidal Particles
|
|
DE102005005449A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
US7759312B2
(en)
*
|
2005-03-11 |
2010-07-20 |
Endo Pharmaceuticals Solutions Inc. |
Delivery of dry formulations of octreotide
|
|
KR101399911B1
(ko)
*
|
2005-03-11 |
2014-06-19 |
엔도 파마슈티컬즈, 솔루션스 아이엔씨. |
옥트레오타이드의 방출 조절형 제형
|
|
WO2007033372A2
(en)
|
2005-09-14 |
2007-03-22 |
Mannkind Corporation |
Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
|
|
US9278161B2
(en)
*
|
2005-09-28 |
2016-03-08 |
Atrium Medical Corporation |
Tissue-separating fatty acid adhesion barrier
|
|
US9427423B2
(en)
|
2009-03-10 |
2016-08-30 |
Atrium Medical Corporation |
Fatty-acid based particles
|
|
EP1933991A4
(en)
|
2005-10-15 |
2012-05-02 |
Atrium Medical Corp |
HYDROPHOBIC NETWORKED GEL FOR BIOABSORBIBLE MEDICINAL CARRIER COVERS
|
|
US7669732B2
(en)
*
|
2005-10-25 |
2010-03-02 |
Imi Cornelius Inc. |
Cup lid dispenser
|
|
AU2007216966C1
(en)
|
2006-02-22 |
2014-03-20 |
Mannkind Corporation |
A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
|
|
EP2012751A4
(en)
*
|
2006-03-21 |
2010-11-24 |
Morehouse School Of Medicine |
NEW NANOPARTICLES FOR THE DELIVERY OF ACTIVE AGENTS
|
|
US8747870B2
(en)
|
2006-04-20 |
2014-06-10 |
University Of Utah Research Foundation |
Polymeric compositions and methods of making and using thereof
|
|
CA2649915A1
(en)
*
|
2006-04-20 |
2007-11-01 |
University Of Utah Research Foundation |
Polymeric compositions and methods of making and using thereof
|
|
GB0613333D0
(en)
|
2006-07-05 |
2006-08-16 |
Controlled Therapeutics Sct |
Hydrophilic polyurethane compositions
|
|
GB0613638D0
(en)
|
2006-07-08 |
2006-08-16 |
Controlled Therapeutics Sct |
Polyurethane elastomers
|
|
US20080075777A1
(en)
*
|
2006-07-31 |
2008-03-27 |
Kennedy Michael T |
Apparatus and methods for preparing solid particles
|
|
ITMI20061545A1
(it)
*
|
2006-08-02 |
2008-02-03 |
Mediolanum Pharmaceuticals Ltd |
Particelle in grado di rilasciare il principio attivo per un periodo prolungato di tempo
|
|
ITMI20061538A1
(it)
*
|
2006-08-02 |
2008-02-03 |
Mediolanum Pharmaceuticals Ltd |
Impianti sottocutanei in grado di rilasciare il principio attivo per un periodo prolungato di tempo
|
|
GB0620685D0
(en)
|
2006-10-18 |
2006-11-29 |
Controlled Therapeutics Sct |
Bioresorbable polymers
|
|
EP2626091B1
(en)
|
2006-11-06 |
2016-09-28 |
Atrium Medical Corporation |
Coated surgical mesh
|
|
US9492596B2
(en)
|
2006-11-06 |
2016-11-15 |
Atrium Medical Corporation |
Barrier layer with underlying medical device and one or more reinforcing support structures
|
|
WO2008112495A1
(en)
*
|
2007-03-09 |
2008-09-18 |
Wyeth |
Synthesis and characterization of polymorph form iii of 4-(2,(4,4-dimethyl-2-oxooxazolidin-3-yl)thiazol-4-yl)benzonitrile
|
|
CN101720239B
(zh)
*
|
2007-04-27 |
2013-12-04 |
恩德制药解决方案公司 |
植入装置脱模剂及其使用方法
|
|
CA3240562A1
(en)
|
2007-12-04 |
2009-06-11 |
Remedy Pharmaceuticals, Inc. |
Improved formulations and methods for lyophilization and lyophilates provided thereby
|
|
US8728528B2
(en)
|
2007-12-20 |
2014-05-20 |
Evonik Corporation |
Process for preparing microparticles having a low residual solvent volume
|
|
EP2249811A1
(en)
|
2008-01-25 |
2010-11-17 |
Grünenthal GmbH |
Pharmaceutical dosage form
|
|
NZ588863A
(en)
*
|
2008-05-09 |
2012-08-31 |
Gruenenthal Chemie |
Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
|
|
WO2009143404A1
(en)
*
|
2008-05-23 |
2009-11-26 |
Wyeth |
Piperazine metabotropic glutamate receptor 5 (mglur5) negative allosteric modulators for anxiety/depression
|
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
|
SG10201507036TA
(en)
|
2008-06-13 |
2015-10-29 |
Mannkind Corp |
A dry powder inhaler and system for drug delivery
|
|
US9364619B2
(en)
|
2008-06-20 |
2016-06-14 |
Mannkind Corporation |
Interactive apparatus and method for real-time profiling of inhalation efforts
|
|
KR20110025974A
(ko)
*
|
2008-06-25 |
2011-03-14 |
엔도 파마슈티컬즈, 솔루션스 아이엔씨. |
이형제를 함유하는 옥트레오티드 이식물
|
|
EP2303226B1
(en)
|
2008-06-25 |
2016-03-23 |
Endo Pharmaceuticals Solutions Inc. |
Sustained delivery of exenatide and other polypeptides
|
|
TWI614024B
(zh)
|
2008-08-11 |
2018-02-11 |
曼凱公司 |
超快起作用胰島素之用途
|
|
US9498431B2
(en)
|
2008-12-10 |
2016-11-22 |
Jianjian Xu |
Controlled releasing composition
|
|
CN102307473A
(zh)
*
|
2008-12-10 |
2012-01-04 |
摩萨纳医疗有限公司 |
可生物降解的生物相容性喜树碱-聚合物共轭物的药物制剂
|
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
|
EP2389160B1
(en)
*
|
2009-01-23 |
2017-09-13 |
Evonik Corporation |
Continuous double emulsion process for making microparticles
|
|
EP2676695A3
(en)
|
2009-03-11 |
2017-03-01 |
MannKind Corporation |
Apparatus, system and method for measuring resistance of an inhaler
|
|
SG176738A1
(en)
|
2009-06-12 |
2012-01-30 |
Mannkind Corp |
Diketopiperazine microparticles with defined specific surface areas
|
|
CN102573806B
(zh)
|
2009-07-22 |
2015-02-25 |
格吕伦塔尔有限公司 |
用于对氧化敏感的阿片类物质的抗破坏剂型
|
|
PE20121067A1
(es)
|
2009-07-22 |
2012-09-05 |
Gruenenthal Chemie |
Forma de dosificacion de liberacion controlada extruida por fusion en caliente
|
|
US20110038910A1
(en)
|
2009-08-11 |
2011-02-17 |
Atrium Medical Corporation |
Anti-infective antimicrobial-containing biomaterials
|
|
WO2011031462A2
(en)
*
|
2009-08-25 |
2011-03-17 |
Latitude Pharmaceuticals Incorporated |
Compositions for delivery of insoluble agents
|
|
CA2775077C
(en)
*
|
2009-09-22 |
2018-05-01 |
Evonik Degussa Corporation |
Implant devices having varying bioactive agent loading configurations
|
|
JP5784622B2
(ja)
|
2009-11-03 |
2015-09-24 |
マンカインド コーポレ−ション |
吸入活動をシミュレートするための装置及び方法
|
|
ES2606227T3
(es)
*
|
2010-02-03 |
2017-03-23 |
Grünenthal GmbH |
Preparación de una composición farmacéutica en polvo mediante una extrusora
|
|
EP2582421A1
(en)
|
2010-06-21 |
2013-04-24 |
MannKind Corporation |
Dry powder drug delivery system and methods
|
|
US10322213B2
(en)
|
2010-07-16 |
2019-06-18 |
Atrium Medical Corporation |
Compositions and methods for altering the rate of hydrolysis of cured oil-based materials
|
|
PL2611425T3
(pl)
|
2010-09-02 |
2014-09-30 |
Gruenenthal Gmbh |
Odporna na ingerencję postać dawki zawierająca polimer anionowy
|
|
PL2611426T3
(pl)
|
2010-09-02 |
2014-09-30 |
Gruenenthal Gmbh |
Postać dawkowania zawierająca nieorganiczne sole, odporna na zgniatanie
|
|
KR102007997B1
(ko)
|
2011-02-07 |
2019-08-07 |
라이프 테크놀로지스 코포레이션 |
감수성 화합물을 안정화시키는 조성물 및 방법
|
|
CA3078334C
(en)
|
2011-04-01 |
2022-08-09 |
Mannkind Corporation |
Blister package for pharmaceutical cartridges
|
|
WO2012172449A1
(en)
|
2011-06-13 |
2012-12-20 |
Pfizer Inc. |
Lactams as beta secretase inhibitors
|
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
|
HRP20171458T1
(hr)
|
2011-07-29 |
2017-11-17 |
Grünenthal GmbH |
Tableta otporna na mijenjanje koja pruža neposredno oslobađanje lijeka
|
|
ES2655900T3
(es)
|
2011-07-29 |
2018-02-22 |
Grünenthal GmbH |
Pastilla a prueba de manipulación que proporciona una liberación inmediata de un medicamento
|
|
AU2012295366B2
(en)
*
|
2011-08-15 |
2017-05-25 |
Jyant Technologies |
Delivery system for specifically targeting cancer cells and method of use thereof
|
|
AU2012328885B2
(en)
|
2011-10-24 |
2017-08-31 |
Mannkind Corporation |
Methods and compositions for treating pain
|
|
EP2790667B1
(en)
|
2011-12-16 |
2017-03-22 |
DSM IP Assets B.V. |
Process for the manufacturing of a drug delivery system based on a polymer comprising a dispersed bioactive agent
|
|
EP2819656A1
(en)
|
2012-02-28 |
2015-01-07 |
Grünenthal GmbH |
Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
|
|
PT2838512T
(pt)
|
2012-04-18 |
2018-11-09 |
Gruenenthal Gmbh |
Forma farmacêutica resistente à adulteração e resistente à libertação inesperada de alta quantidade (dose-dumping)
|
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
|
US9867880B2
(en)
|
2012-06-13 |
2018-01-16 |
Atrium Medical Corporation |
Cured oil-hydrogel biomaterial compositions for controlled drug delivery
|
|
EP2872205B1
(en)
|
2012-07-12 |
2017-02-08 |
MannKind Corporation |
Dry powder drug delivery systems
|
|
US10159644B2
(en)
|
2012-10-26 |
2018-12-25 |
Mannkind Corporation |
Inhalable vaccine compositions and methods
|
|
KR102246914B1
(ko)
|
2013-03-15 |
2021-04-30 |
맨카인드 코포레이션 |
미세결정성 디케토피페라진 조성물 및 방법
|
|
EP3003279A1
(en)
|
2013-05-29 |
2016-04-13 |
Grünenthal GmbH |
Tamper-resistant dosage form containing one or more particles
|
|
MX2015016254A
(es)
|
2013-05-29 |
2016-04-20 |
Gruenenthal Gmbh |
Forma de dosificacion resistente al uso indebido con perfil de liberacion bimodal.
|
|
MX368846B
(es)
|
2013-07-12 |
2019-10-18 |
Gruenenthal Gmbh |
Forma de dosificación resistente a la alteración que contiene polímero de acetato de etilen-vinilo.
|
|
US9925144B2
(en)
|
2013-07-18 |
2018-03-27 |
Mannkind Corporation |
Heat-stable dry powder pharmaceutical compositions and methods
|
|
US11446127B2
(en)
|
2013-08-05 |
2022-09-20 |
Mannkind Corporation |
Insufflation apparatus and methods
|
|
EP3073994A1
(en)
*
|
2013-11-26 |
2016-10-05 |
Grünenthal GmbH |
Preparation of a powdery pharmaceutical composition by means of cryo-milling
|
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
|
EP3142646A1
(en)
|
2014-05-12 |
2017-03-22 |
Grünenthal GmbH |
Tamper resistant immediate release capsule formulation comprising tapentadol
|
|
JP2017516789A
(ja)
|
2014-05-26 |
2017-06-22 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
エタノール過量放出に対して防護されている多粒子
|
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
|
AU2016251854A1
(en)
|
2015-04-24 |
2017-10-19 |
Grunenthal Gmbh |
Tamper-resistant dosage form with immediate release and resistance against solvent extraction
|
|
EP3346991A1
(en)
|
2015-09-10 |
2018-07-18 |
Grünenthal GmbH |
Protecting oral overdose with abuse deterrent immediate release formulations
|
|
CA3004363A1
(en)
|
2015-11-06 |
2017-05-11 |
Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. |
Composition comprising a biocompatible and biodegradable polymer, nanocarries and a drug and methods of making and using the same
|